Mineralys Therapeutics, Inc. (MLYS)
Mineralys Therapeutics (MLYS) is seeing increased social media buzz around its Phase [--] trials, with top creators highlighting upcoming catalysts. Despite this, recent price action shows volatility near its 52-week high.
About Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for cardiovascular and renal diseases.
Mineralys Therapeutics, Inc. uses the ticker $MLYS for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Mineralys Therapeutics, Inc. (MLYS) creators is up 77.63% from the previous month.
- Mineralys Therapeutics, Inc. (MLYS) engagements is up 42.97% from the previous week.
- Mineralys Therapeutics, Inc. (MLYS) mentions is up 106.54% from the previous month.
- Mineralys Therapeutics, Inc. (MLYS) posts created is up 93.33% from the previous week.
Price: $27.60
Price 24-Hour Time-Series Raw Data
The stock price is experiencing volatility near its 52-week high, potentially due to decreased social mentions and creator activity, suggesting a short-term correction despite positive trial results and analyst upgrades.
24-Hour: 0.99% 7-Day: -8.82% 30-Day: -15.7%
1-Year High: $47.30 on 2025-11-12
1-Year Low: $8.80 on 2025-02-25
AltRank: [-----]
AltRank 24-Hour Time-Series Raw Data
Mineralys Therapeutics, Inc. (MLYS) is currently AltRank #1,084 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] +87
[--] Month: [---] +875
[--] Months: [---] +185
[--] Year: [---] +362
1-Year High: [-----] on 2025-11-06
1-Year Low: [--] on 2025-09-21
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-03-10
1-Year Low: [--] on 2025-04-25
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [-----]
[--] Week: [------] +43%
[--] Month: [-------] -6.50%
[--] Months: [---------] +53%
[--] Year: [---------] +157%
1-Year High: [-------] on 2025-09-02
1-Year Low: [---] on 2025-08-09
Engagements by network (24h): Reddit: [--] X: [------] YouTube: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +30%
[--] Month: [---] +107%
[--] Months: [-----] +61%
[--] Year: [-----] +779%
1-Year High: [---] on 2025-09-03
1-Year Low: [--] on 2025-08-09
Mentions by network (24h): Reddit: [--] X: [--] YouTube: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Mineralys Therapeutics, Inc. (MLYS) in the last [--] hours which is up 26% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] +24%
[--] Month: [---] +78%
[--] Months: [---] -7.30%
[--] Year: [-----] +687%
1-Year High: [---] on 2025-06-29
1-Year Low: [--] on 2025-08-18
The most influential creators that mention Mineralys Therapeutics, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | [--] | [------] | [--] | [-----] |
| @Andre_AGTC | [--] | [-----] | [--] | [---] |
| @Mineralystx | [--] | [---] | [--] | [--] |
| @Angelinafrazier | [--] | [--] | [--] | |
| @Ellie18153 | [--] | [--] | [--] | [--] |
| @Stock_Analysis8 | [--] | [--] | [--] | [--] |
| @David_Tonkinn | [--] | [--] | [--] | [--] |
| @TreyHendrickzyn | [--] | [---] | [--] | [--] |
| @BiseasShre94554 | [--] | [--] | [--] | [--] |
| @Stock_Marketr18 | [--] | [--] | [--] | [--] |
Sentiment: 33%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 33%
Daily Average: 77%
[--] Week: 33% -9%
[--] Month: 22% -18%
[--] Months: 22% -78%
[--] Year: 22% -78%
1-Year High: 100% on 2025-02-17
1-Year Low: 15% on 2025-12-29
Most Supportive Themes:
- Director Share Purchase: (40%) Director Srinivas Akkaraju purchased $15M in shares, signaling confidence.
Most Critical Themes:
- Declining Social Activity: (30%) Mentions of MLYS are down 77% and creators mentioning MLYS are down 84% over the last month.
Social Dominance: 0.0056%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0056%
Daily Average: 0.00905%
[--] Week: 0.0071% -0.0034%
[--] Month: 0.0021% -0.021%
[--] Months: 0.0021% -0.001%
[--] Year: 0.0021% -0.0056%
1-Year High: 0.061% on 2025-09-03
1-Year Low: 0.0013% on 2025-08-09
Market Dominance: 0.00251%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00251%
Daily Average: 0%
1-Year High: 0.00448% on 2025-11-12
1-Year Low: 0.00251% on 2026-02-16
Market Cap: $2,215,918,768
Market Cap 24-Hour Time-Series Raw Data
Current Value: $2,215,918,768
Daily Average: $2,943,303,947
[--] Week: $2,215,918,768 -12%
[--] Month: $2,184,262,786 -16%
1-Year High: $3,745,694,117 on 2025-11-12
1-Year Low: $2,184,262,786 on 2026-02-13
Top Mineralys Therapeutics, Inc. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $BIVI Phase [--] $MDNAF Phase 2b $DBVT Phase [--] $GOSS Phase [--] $MLTX Phase [--] $BFRI Phase [--] $BCDA Phase [--] $KPTI Phase [--] $IOVA Phase [--] $XENE Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $ALZN Phase [--] $HELP Phase [--] $PVLA Phase [--] $INSM"
X Link @BiopharmIQ 2026-02-15T19:38Z 28.9K followers, [----] engagements
"My watch list of catalysts 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA $CMPS Ph3 TRD $HELP Ph2 GAD My watch list near term catalysts 👍$NKTR 36w AD $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $BBIO Ph3 ACH $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA + NDA HTN $CMPS Ph3 TRD $HELP Ph2 GAD $BLTE NDA STGD1 H1 My watch list near term catalysts 👍$NKTR 36w AD $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3"
X Link @Andre_AGTC 2026-02-12T14:13Z [----] followers, [----] engagements
"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $MDNAF Phase 2b $GOSS Phase [--] $BFRI Phase [--] $MLTX Phase [--] $BFRI Phase [--] $BCDA Phase [--] $KPTI Phase [--] $IOVA Phase [--] $XENE Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $ZBIO Phase [--] $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $NKTR Phase 2b $ALZN Phase [--] $HELP Phase [--] $PVLA"
X Link @BiopharmIQ 2026-02-08T18:59Z 28.9K followers, 20.4K engagements
"End of [----] update Top 10+15 $MDGL NASH $KRYS DEB $AXSM MDD ADA $XENE FOS $RVMD RASmuti $PRAX ET $ABVX IBD $BBIO ATTR $MIRM IBAT $CTYK oHCM $CRNX $SRRK $NKTR $NUVL $VKTX $IMVT $VTYX $CYBN $ABEO $BLTE $CPRX $ALNY $MLYS $VRDN $KYMR Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY RNAi $CPRX $ABEO $CORT $KYMR $NUVL $QURE $IMCR $NBIX $VKTX $MLYS Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY"
X Link @Andre_AGTC 2025-12-31T18:48Z [----] followers, 17.5K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing